Viatris
VTRS
NZ$15.42
Share price
-0.76%
Change (1 day)
-23.52%
Change (1 year)
Categories
Revenue for Viatris (VTRS)
Revenue in 2025 (TTM): NZ$24.13 Billion
According to Viatris's latest financial reports the company's current revenue (TTM 
) is NZ$24.04 Billion. In 2024 the company made a revenue of NZ$26.13 Billion an increase over the revenue in the year 2023 that were of NZ$24.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Viatris from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | NZ$24.13 B | -7.67% |
| 2024 | NZ$26.13 B | 7.14% |
| 2023 | NZ$24.39 B | -4.76% |
| 2022 | NZ$25.61 B | -2.18% |
| 2021 | NZ$26.18 B | 58.17% |
| 2020 | NZ$16.55 B | -3.05% |
| 2019 | NZ$17.07 B | 0.18% |
| 2018 | NZ$17.04 B | 1.67% |
| 2017 | NZ$16.76 B | 4.85% |
| 2016 | NZ$15.99 B | 16.07% |
| 2015 | NZ$13.77 B | 39.83% |
| 2014 | NZ$9.85 B | 17.18% |
| 2013 | NZ$8.40 B | 2.08% |
| 2012 | NZ$8.23 B | 4.87% |
| 2011 | NZ$7.85 B | 11.17% |
| 2010 | NZ$7.06 B | 0.76% |
| 2009 | NZ$7.01 B | -20.8% |
| 2008 | NZ$8.85 B | |
| 2006 | NZ$2.16 B | 18.41% |
| 2005 | NZ$1.82 B | 2.65% |
| 2004 | NZ$1.78 B | -17.04% |
| 2003 | NZ$2.14 B | -6.26% |
| 2002 | NZ$2.28 B | -11.16% |
| 2001 | NZ$2.57 B | 40.52% |
| 2000 | NZ$1.83 B | 25.1% |
| 1999 | NZ$1.46 B | 15.93% |
| 1998 | NZ$1.26 B | 43.49% |
| 1997 | NZ$0.88 B | 49.6% |
| 1996 | NZ$0.58 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | NZ$0.37 M | -100.00% | 🇺🇸 USA |
 OPKO Health
OPK | NZ$1.15 B | -95.19% | 🇺🇸 USA |